The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 244 participants.
Also called NCT05811364
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 244 participants
- Sponsor
- Registry
-
NCT05811364
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Germany, Italy, Netherlands, New Zealand, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT05811364. Randomized; double masking; primary purpose treatment. Start 2023-10-17 (actual); primary completion 2028-03-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
- Condition
- Aortoiliac Occlusive Disease
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- Stenting of the Common and/or External Iliac Arteries with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis
- Intervention (Device)
- Stenting of the Common and/or External Iliac Arteries with Bare Metal Stent
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct05811364- Content hash
5156d692f33edeb15fd09887c380051c9f60111eff9ed0cd77ef01f74302913c